ZETRISIL® – HOW DOES IT HELP WITH WOUND HEALING?
Zetrisil® is a proprietary nano-based silicone compound combined with conventional quaternary ammonium compounds, that effectively protects and/or “shields” the effected area from bacterial contamination, by way of a long-lasting, cationic charged, anti microbial nano silicone coating.
TOPICAL ANTISEPTIC GEL – THE WOUND CARE MIRACLE
My-shield® Topical Antiseptic Gel, is a USA, GLP (Good Laboratory Practice) manufactured nano silicone/based FDA approved, over-the-counter, 0.13% Benzalkonium chloride pre-priority formulation that is designed speciﬁcally to promote rapid infection free healing of minor cuts, deep wounds, abrasions and burns. It is superior to all current prescription and OTC (over-the-counter) products available in the USA today for such medical issue treatment protocols.
My-shield® Topical Antiseptic Gel was developed to provide long-lasting, alcohol-free protection from germs when applied to minor cuts, deep wounds, abrasions and burns. With the addition of the proprietary formula Zertrisil®, it not only controls wound bacterial contamination, but it promotes rapid wound healing & prevents future bacterial wound re-infections.
We present photos to illustrate wound healing progress for 2 cases below. Imagine what this antiseptic gel can do for you. More clinical information is available through link at bottom of page.
TREATMENT DETAILS FOR CASE 1 (LEG):
My-shield® Topical Antiseptic Gel was applied liberally over the entire wound, covered with sterile petrolatum mesh (note crosshatched pattern on new tissue) and covered with Teﬂon non-adherent dressing and padded with dry gauze and wrapped with roller gauze to avoid tape contacting the skin. The treatment process was repeated once daily from the 26th of April, 2019 to the 3rd of May, 2019 when the Teﬂon dressing was discontinued due to minimal wound exudate. My-shield® Topical Antiseptic Gel was continued through May 20th, 2019 (complete wound closure) with recommended follow up application of My-shield® Topical Antiseptic Gel once daily for 7 more days. Wound debridement was never attempted due to patient’s emotional state and was found to be completely unnecessary due to the speed of wound remodeling, closure and healing.
4/26/19 5/03/19 (7 Days) 5/22/19 (25 Days) 6/04/19 (38 Days)
TREATMENT DETAILS FOR CASE 2 (TEMPLE):
Image #1 below shows the wound when the ﬁrst dressing was removed and wife and Home Care RN were told to apply My-shield® Topical Antiseptic Gel once daily, then cover with Telfa and then Vasoline gauze to prevent sticking to the wound. There was no debridement done at any time with this wound and all bioﬁlm removal was accomplished with My-shield® Topical Antiseptic Gel breaking it down daily. Dressing was changed once daily through the series of pictures with Vasoline gauze discontinued when wound discharge resolved. Telfa and gel continued through complete healing.
5/20/19 5/23/19 (3 Days) 5/27/19 (7 Days) 6/01/19 (12 Days)
Click here to see Clinical Trial Product Results – Topical Antiseptic – Wound Brochure.